Overview

Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents

Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the safety and effectiveness of clozapine in children and adolescents with treatment resistant bipolar disorder. This study will also explore how the brain functions in early-onset bipolar disorder.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Institute of Mental Health (NIMH)
Treatments:
Clozapine
Criteria
INCLUSION CRITERIA (All 5 must be met): Children with BPD

Ages 8-17

Currently meets criteria for bipolar disorder, manic or mixed, as determined by the K-SADS
diagnostic interview.

Treatment-resistant, defined as a history of unsuccessful trials of lithium (documented
level of greater than 0.8 mEq/L), valproic acid (documented level of greater than 50
ug/ml), carbamazepine (documented level greater than or equal to 6 ug/ml), a neuroleptic as
well as a combination of two of these agents. Each trial must have been at least 6 weeks
long. A trial will be considered unsuccessful if the medication was discontinued because of
intolerable side-effects.

The child should be in treatment with a community psychiatrist to whom they will return
upon completion of the study.

Current CGAS score less than 50

EXCLUSION CRITERIA: Children with BPD

Full scale IQ less than 80

Meets criteria for substance use disorder in the three months prior to randomization

Currently pregnant, lactating, or sexually active without using a barrier method of
contraception

Previous treatment with clozapine

History of seizures

History of leukopenia or agranulocytosis

Presence of an unstable medical illness

INCLUSION CRITERIA: CONTROLS

Control subjects will be age- and sex- matched to the BPD subjects. They will have normal
physical and neurological examinations, and an identified primary care physician. Both
control subjects and their first-degree relatives must be free of current or past
psychopathology.

EXCLUSION CRITERIA: CONTROLS

I.Q less than 80; ongoing medical illness; neurologic disorder (including seizures);
pregnancy; meeting past or present criteria for any diagnosis on the K-SADS-PL; meeting
criterion A of post-traumatic stress disorder (exposure to a traumatic event).